NCT07659548 · NOT YET RECRUITING

Home-based Monitoring & Enabled Medication Independence With New Digital Tools

This trial is testing a digital self-monitoring platform called HOME-MIND designed to help older adults who live alone and have early memory concerns manage multiple medications more safely at home. Participants log symptoms and concerns, get guidance, and can share reports with their care team. This is a Phase NA behavioral study — it is evaluating a tool or approach, not a drug, and is not yet proven or approved.

You may qualify if

  • Older adults (≥ 65 years old)
  • Living alone (in a non-institutional setting without others)
  • With subjective or mild cognitive decline (a screening test to confirm)
  • Taking at least five prescribed medications concurrently
  • With suboptimal self-reported medication adherence (a screening test to confirm)
  • Having access to a computer or mobile device and internet service
  • Able to read and speak English

You're excluded if

  • Having severe cognitive, vision, hearing, or other impairment
  • Unable to use computers or mobile devices
  • Relying on someone else to manage medications

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-06-22

View full record on ClinicalTrials.gov

All APOE4 clinical trials